학술논문
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2022, 13(1))
Subject
Language
English
ISSN
20411723